Last edition
News about "Cellgorithm platform"
Syntax Bio and Mayo Clinic Partner on Type 1 Diabetes Cell Therapy
Syntax Bio and Mayo Clinic have partnered to accelerate the development of stem cell-derived pancreatic cell therapies for Type 1 Diabetes (T1D). The collaboration aims to advance regenerative medicine approaches that could restore insulin-producing cells.
Cellgorithm Platform | 10/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members